| # | Title | Journal | Year | Citations |
|---|
| 1 | Antibiotics versus biofilm: an emerging battleground in microbial communities | Antimicrobial Resistance and Infection Control | 2019 | 856 |
| 2 | The threat of antimicrobial resistance in developing countries: causes and control strategies | Antimicrobial Resistance and Infection Control | 2017 | 714 |
| 3 | First hospital outbreak of the globally emerging Candida auris in a European hospital | Antimicrobial Resistance and Infection Control | 2016 | 535 |
| 4 | Review on plant antimicrobials: a mechanistic viewpoint | Antimicrobial Resistance and Infection Control | 2019 | 445 |
| 5 | Catheter associated urinary tract infections | Antimicrobial Resistance and Infection Control | 2014 | 351 |
| 6 | Estimating the burden of antimicrobial resistance: a systematic literature review | Antimicrobial Resistance and Infection Control | 2018 | 341 |
| 7 | Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum | Antimicrobial Resistance and Infection Control | 2013 | 316 |
| 8 | Modern technologies for improving cleaning and disinfection of environmental surfaces in hospitals | Antimicrobial Resistance and Infection Control | 2016 | 288 |
| 9 | Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action | Antimicrobial Resistance and Infection Control | 2012 | 277 |
| 10 | Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations | Antimicrobial Resistance and Infection Control | 2017 | 277 |
| 11 | Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis | Antimicrobial Resistance and Infection Control | 2014 | 233 |
| 12 | Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review | Antimicrobial Resistance and Infection Control | 2019 | 233 |
| 13 | Nosocomial transmission and outbreaks of coronavirus disease 2019: the need to protect both patients and healthcare workers | Antimicrobial Resistance and Infection Control | 2021 | 207 |
| 14 | Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review | Antimicrobial Resistance and Infection Control | 2019 | 192 |
| 15 | Risk of SARS-CoV-2 transmission by aerosols, the rational use of masks, and protection of healthcare workers from COVID-19 | Antimicrobial Resistance and Infection Control | 2020 | 188 |
| 16 | Epidemiology of Clostridium difficile infection in Asia | Antimicrobial Resistance and Infection Control | 2013 | 186 |
| 17 | Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control | Antimicrobial Resistance and Infection Control | 2017 | 186 |
| 18 | World Health Organization (WHO) guidelines on use of medically important antimicrobials in food-producing animals | Antimicrobial Resistance and Infection Control | 2018 | 179 |
| 19 | The gut is the epicentre of antibiotic resistance | Antimicrobial Resistance and Infection Control | 2012 | 158 |
| 20 | Antimicrobial resistance: one world, one fight! | Antimicrobial Resistance and Infection Control | 2015 | 158 |
| 21 | Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis | Antimicrobial Resistance and Infection Control | 2018 | 154 |
| 22 | Clinical characteristics, antimicrobial resistance and capsular types of community-acquired, healthcare-associated, and nosocomial Klebsiella pneumoniae bacteremia | Antimicrobial Resistance and Infection Control | 2019 | 150 |
| 23 | Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use | Antimicrobial Resistance and Infection Control | 2018 | 149 |
| 24 | Economic burden of nosocomial infections caused by vancomycin-resistant enterococci | Antimicrobial Resistance and Infection Control | 2018 | 144 |
| 25 | Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture | Antimicrobial Resistance and Infection Control | 2021 | 137 |
| 26 | Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis | Antimicrobial Resistance and Infection Control | 2020 | 134 |
| 27 | Biofilm exacerbates antibiotic resistance: Is this a current oversight in antimicrobial stewardship? | Antimicrobial Resistance and Infection Control | 2020 | 129 |
| 28 | European intensive care physicians’ experience of infections due to antibiotic-resistant bacteria | Antimicrobial Resistance and Infection Control | 2020 | 128 |
| 29 | An outbreak of carbapenem-resistant OXA-48 – producing Klebsiella pneumonia associated to duodenoscopy | Antimicrobial Resistance and Infection Control | 2015 | 121 |
| 30 | Extended-spectrum beta-lactamase production and multi-drug resistance among Enterobacteriaceae isolated in Addis Ababa, Ethiopia | Antimicrobial Resistance and Infection Control | 2019 | 118 |
| 31 | Antimicrobial use and resistance in food-producing animals and the environment: an African perspective | Antimicrobial Resistance and Infection Control | 2020 | 116 |
| 32 | First detection of Klebsiella variicola producing OXA-181 carbapenemase in fresh vegetable imported from Asia to Switzerland | Antimicrobial Resistance and Infection Control | 2015 | 110 |
| 33 | Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany − 10 years of surveillance | Antimicrobial Resistance and Infection Control | 2018 | 108 |
| 34 | Antimicrobial use in Chinese swine and broiler poultry production | Antimicrobial Resistance and Infection Control | 2015 | 106 |
| 35 | Migrant and refugee populations: a public health and policy perspective on a continuing global crisis | Antimicrobial Resistance and Infection Control | 2018 | 103 |
| 36 | High rates of multidrug resistance among uropathogenic Escherichia coli in children and analyses of ESBL producers from Nepal | Antimicrobial Resistance and Infection Control | 2017 | 102 |
| 37 | Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019–June 2021) | Antimicrobial Resistance and Infection Control | 2022 | 102 |
| 38 | Genome-based analysis of Carbapenemase-producing Klebsiella pneumoniae isolates from German hospital patients, 2008-2014 | Antimicrobial Resistance and Infection Control | 2018 | 100 |
| 39 | High burden of antimicrobial resistance among gram negative bacteria causing healthcare associated infections in a critical care unit of Nepal | Antimicrobial Resistance and Infection Control | 2017 | 99 |
| 40 | Enhancing pharmacists’ role in developing countries to overcome the challenge of antimicrobial resistance: a narrative review | Antimicrobial Resistance and Infection Control | 2018 | 99 |
| 41 | Surface micropattern limits bacterial contamination | Antimicrobial Resistance and Infection Control | 2014 | 98 |
| 42 | Epidemiology and molecular characterization of multidrug-resistant Gram-negative bacteria in Southeast Asia | Antimicrobial Resistance and Infection Control | 2016 | 98 |
| 43 | Complications with peripherally inserted central catheters (PICCs) used in hospitalized patients and outpatients: a prospective cohort study | Antimicrobial Resistance and Infection Control | 2017 | 98 |
| 44 | A review of 40 years of enteric antimicrobial resistance research in Eastern Africa: what can be done better? | Antimicrobial Resistance and Infection Control | 2015 | 97 |
| 45 | Selection and dissemination of antimicrobial resistance in Agri-food production | Antimicrobial Resistance and Infection Control | 2019 | 97 |
| 46 | Incidence and predictors of surgical site infections following caesarean sections at Bugando Medical Centre, Mwanza, Tanzania | Antimicrobial Resistance and Infection Control | 2014 | 93 |
| 47 | Shiga (Vero)-toxin producing Escherichia coli isolated from the hospital foods; virulence factors, o-serogroups and antimicrobial resistance properties | Antimicrobial Resistance and Infection Control | 2017 | 92 |
| 48 | Multidrug-resistant gram-negative bacterial infections in a teaching hospital in Ghana | Antimicrobial Resistance and Infection Control | 2018 | 92 |
| 49 | The prevalence of antimicrobial resistance in clinical isolates from Gulf Corporation Council countries | Antimicrobial Resistance and Infection Control | 2012 | 89 |
| 50 | Implementation and impact of pediatric antimicrobial stewardship programs: a systematic scoping review | Antimicrobial Resistance and Infection Control | 2020 | 89 |
